MARGARET ERDMAN: Open Payments
NPI 1275836546 · WEST ALLIS, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,634 in 89 payments from 16 companies in 2025. Trend: 2023 $1,341 · 2024 $1,081 · 2025 $1,634
Food & beverage: $1,627Education: $7
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $310 |
| Neurocrine BioSciences, Inc. | 15 | $257 |
| Supernus Pharmaceuticals, Inc. | 19 | $227 |
| Vanda Pharmaceuticals Inc. | 10 | $187 |
| Janssen Pharmaceuticals, Inc | 11 | $151 |
| Otsuka America Pharmaceutical, Inc. | 5 | $106 |
| Teva Pharmaceuticals USA, Inc. | 4 | $101 |
| Lundbeck LLC | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
Products named: ARISTADA, INGREZZA, Qelbree, FANAPT, REXULTI, AUSTEDO XR, INVEGA SUSTENNA, SPRAVATO.
Industry payments across WI — which companies pay providers there.
